INVESTORS

AT A GLANCE

"A pioneer of digital therapeutics, Voluntis was the first such company to go public. Personally, and in the name of the entire Voluntis team, I would like to thank all of our new and historic shareholders for their faith in us. This investment of €30.1M will allow us to continue our commitment to patients and healthcare professionals, helping them better manage treatment in the hopes that this improves real-world efficacy." - Pierre Leurent, CEO of Voluntis

STOCK INFORMATION

EURONEXT Paris

WHAT'S NEW

Upcoming events

19 Sept. 2019

2019 H1 Results

CONFERENCE CALL

2018 Financial Results

ANNUAL RESULTS

2018 Annual Results Investor Call

PRESS RELEASES

DOCUMENTS

Sorry, but ther are no document, please choose other criterias

CONTACT THE INVESTOR RELATIONS TEAM

NewCap
Louis-Victor Delouvrier
21, place de la Madeleine
75008 Paris, France
Tel: +33 (0)1 44 71 94 94
Email: voluntis@newcap.eu